title: Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization.
abstract: Cardiogenic shock remains a highly lethal condition. Conventional therapy including revascularization and mechanical circulatory support aims to improve cardiac output and oxygen delivery, but increasing basic and clinical observations indicate wider circulatory and cellular abnormalities, particularly at the advanced stages of shock. Progressive cardiogenic shock is associated with microcirculatory and cellular abnormalities. Cardiogenic shock is initially characterized by a failure to maintain global oxygen delivery; however, progressive cardiogenic shock is associated with the release of pro-inflammatory cytokines, derangement of the regulation of regional blood flow, microcirculatory abnormalities, and cellular dysoxia. These abnormalities are analogous to septic shock and may not be reversed by increase in oxygen delivery, even to supranormal levels. Earlier mechanical circulatory support in cardiogenic shock may limit the development of microcirculatory and cellular abnormalities.
authors: Department of Cardiology, University Hospital Birmingham NHS Trust, Birmingham, United Kingdom.
authors: Hoong Sern
authors: HS
authors: Lim
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D015687:Cell Hypoxia; D060833:Cellular Microenvironment; D004058:Diffusion; D006439:Hemodynamics; D006801:Humans; D008833:Microcirculation; D008955:Models, Cardiovascular; D010100:Oxygen / Q000097:blood*; D010101:Oxygen Consumption; D010102:Oxygen Inhalation Therapy; D012039:Regional Blood Flow; D012770:Shock, Cardiogenic / Q000097:blood* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy
chemical_list: D015415:Biomarkers; D010100:Oxygen